# Lisata Therapeutics, Inc.: Form 8-K, filed Dec 3, 2024

- Company: [Lisata Therapeutics, Inc.](/companies/lsta.md) (CIK 320017)
- Form: 8-K
- Filed: 2024-12-03
- Accepted by EDGAR: Dec 3, 2024, 08:33 ET
- Period: 2024-12-03
- Accession: 0000320017-24-000061
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/320017/000032001724000061/clbs-20241203.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/320017/000032001724000061/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/320017/000032001724000061/clbs-20241203.htm

Filed Dec 3, 2024.
Source: SEC EDGAR, the filing index for accession 0000320017-24-000061. Last ingested by Listed: Nov 14, 2026, 19:21 ET. No prices; not investment advice.
